CCK-8,
CCK-OP,
Cholecystokinin Octapeptide,
Cholecystokinin Pancreozymin C Terminal Octapeptide,
Cholecystokinin Pancreozymin C-Terminal Octapeptide,
H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,
Kinevac,
OP-CCK,
Sincalide,
SQ 19,844,
SQ 19844,
SQ-19,844,
SQ-19844,
SQ19,844,
SQ19844,
Syncalide,
Sincalide,
25126-32-3,
CCK-8,
UNII-M03GIQ7Z6P,
Kinevac,
CHEMBL1121,
M03GIQ7Z6P,
MFCD00079849,
SQ 19844,
Sincalidum [INN-Latin],
Sincalida [INN-Spanish],
Cholecystokinin octapeptide,
cholecystokinin 8,
DSSTox_CID_28543,
DSSTox_RID_82815,
DSSTox_GSID_48617,
Sincalidum,
Sincalida,
Syncalide,
EINECS 246-639-0,
CAS-25126-32-3,
Human CCK-8,
Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-,
CCK-8 (sulphated),
Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,
Pancreozymin,
SQ-19844,
Pancreozymin C-terminal octapeptide,
1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein,
Sincalide [USAN:USP:INN:BAN],
NCGC00183278-01,
NCGC00183363-01,
L-alpha-Aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide,
L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide hydrogen sulfate (ester),
C49H62N10O16S3,
Kinevac (TN),
cholecystokinin C-terminal octapeptide,
Sincalide (Kinevac),
Sincalide (USP/INN),
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide,
CCK C-terminal octapeptide,
Cholecystokinin-pancreozymin,
cholecystokinin fragment 26-33 amide (sulphated),
H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,
GTPL864,
SCHEMBL122365,
CCK-8(SO3),
DTXSID7048617,
BDBM21147,
CHEBI:135946,
IZTQOLKUZKXIRV-YRVFCXMDSA-N,
[125I]CCK-8,
HY-P0093,
3-10-Caerulein, 5-L-methionine-,
Tox21_112955,
Tox21_113481,
Cholecystokinin Octapeptide, sulfated,
AKOS016340423,
CS-5963,
DB09142,
HS-2026,
NCGC00167273-01,
O411,
SC-47569,
Cholecystokinin, CCK Octapeptide (26-33),
FT-0630515,
D05845,
Asp26-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-PheNH2,
126S323,
A817659,
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid,
(3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid,
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-(methylth,
(3S)-3-azanyl-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanyl,
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosane-1,23-dioic acid,
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosane-1,23-dioic acid,
Sincalid,
Cholecystokinin-8,
CCK 8 amide,
CHOLECYSTOKININ,
CCK-OP,
OP-CCK,
CCK Octapeptide, sulfated,
D0I8AF,
Sincalide [USAN:BAN:INN],
Sincalide [USAN:INN:BAN],
CCK (1-8),
ACN-053730,
CID9833444,
SQ19844,
SQ19,844,
C49-H62-N10-O16-S3,
SQ 19,844,
SQ-19,844,
C410885,
Cholecystokinin Pancreozymin C Terminal Octapeptide,
Cholecystokinin Pancreozymin C-Terminal Octapeptide,
D012844,